MLPA and MAPH: New techniques for detection of gene deletions
Open Access
- 19 March 2004
- journal article
- review article
- Published by Hindawi Limited in Human Mutation
- Vol. 23 (5) , 413-419
- https://doi.org/10.1002/humu.20035
Abstract
Screening for deletions of all or part of genes poses a challenge in the diagnostic laboratory. Numerous methods are available for detecting deletions of a few base pairs or very large deletions, but difficulties arise in detecting deletions of a few kilobases. Two new techniques have recently been described that allow detection of such mid‐size deletions by simultaneously screening for the loss or duplication of up to 40 target sequences. These are the multiplex amplification and probe hybridization (MAPH) and the multiplex ligation‐dependent probe amplification (MLPA). Both rely on sequence‐specific probe hybridization to genomic DNA, followed by amplification of the hybridized probe, and semi‐quantitative analysis of the resulting PCR products. The relative peak heights or band intensities from each target indicate their initial concentration. The two techniques differ in the ease with which probes can be generated in house, and the labor intensity of performing the assay. Hum Mutat 23:413–419, 2004.Keywords
This publication has 17 references indexed in Scilit:
- Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer familiesHuman Molecular Genetics, 2003
- High‐resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probesGenes, Chromosomes and Cancer, 2003
- High throughput screening of human subtelomeric DNA for copy number changes using multiplex amplifiable probe hybridisation (MAPH)Journal of Medical Genetics, 2002
- Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approachBritish Journal of Cancer, 2002
- Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer familiesOncogene, 2002
- Correlation of allelic losses and clinicopathological factors in 504 primary breast cancersBreast Cancer, 2002
- The development and clinical use of trastuzumab (Herceptin).Endocrine-Related Cancer, 2002
- Prognostic Impact of Multiple Allelic Losses on Metastatic Recurrence in Hepatocellular Carcinoma after Curative ResectionOncology, 2002
- Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2Nature Biotechnology, 2000
- Measurement of locus copy number by hybridisation with amplifiable probesNucleic Acids Research, 2000